Low-dose dexamethasone challenge in women with atypical major depression: Pilot study

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 1, 2002, Pages 47-51

  Levitan, Robert D ^a   Vaccarino, Franco J ^a   Brown, Gregory M ^a   Kennedy, Sidney H ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Corticotropin releasing hormone; Depression, atypical, dexamethasone; Hormones; Hydrocortisone; Mood disorders; Stress

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MELANCHOLIA; NEGATIVE FEEDBACK; REGULATORY MECHANISM;

ADULT; ANTI-INFLAMMATORY AGENTS; BODY MASS INDEX; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PILOT PROJECTS; PITUITARY-ADRENAL SYSTEM;

EID: 0036256905     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Defining the boundaries of atypical depression
2. Atypical depression
3. Atypical depression. A valid clinical entity?
4. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo
5. Clinical significance of psychoneuroendocrinology in psychiatry: Focus on the thyroid and adrenal
6. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features
7. Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: A case series
8. Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression
9. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: Clinical and pathophysiological implications
10. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of anti-depressant drugs
11. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
12. Use of the dexamethasone suppression test in depression
13. Major depression in individuals with a history of childhood physical or sexual abuse: Relationship to neurovegetative features, mania, and gender
14. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse